SCI & TECH● LOWAug 19 · Aug 19, 2026, 10:49 AM
Personalized cancer vaccine from Moderna, Merck shows promise in first late-stage melanoma trial
CNBC
The combination regimen significantly extended the time patients lived without their melanoma returning, compared with Keytruda alone.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Sci & Tech
SCI & TECH38m agoWhy China’s new estimate on Greenland ice loss speed is 55% lower than America’sSouth China Morning PostSCI & TECH1h agoChristopher Johnson, marine scientist on blue whale conservation: "The decisions we make now will influence that recovery"ClarínSCI & TECH1h agoHow AI is transforming hurricane forecastsNPR NewsSCI & TECH1h agoWhat are microchimeric cells doing to our brain?New Scientist